Crowell Gayle A Insider Trades

Insider Trading History

Track insider trading activity for Crowell Gayle A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $2.45M 97,589 shares
Last Trade
Mar 26, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$183k 7,317 shares
$24.99
$25.10
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $1.52M 97,589 shares
Last Trade
Mar 26, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$105k 7,317 shares
$14.35
$15.57
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $2.2M 87,458 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$168k 6,600 shares
$25.45
$25.10
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $1.36M 87,458 shares
Last Trade
Feb 23, 2026 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$100k 6,600 shares
$15.20
$15.57
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $1.23M 78,727 shares
Last Trade
Nov 03, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$107k 6,000 shares
$17.77
$15.57
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $1.98M 78,727 shares
Last Trade
Nov 03, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$151k 6,000 shares
$25.12
$25.10
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $35.1k 30,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$1.17
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $1.74M 69,344 shares
Last Trade
May 08, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$150k 5,999 shares
$25.00
$25.10
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $1.08M 69,344 shares
Last Trade
May 08, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$105k 5,999 shares
$17.49
$15.57
Envestnet
Envestnet ENV
Director
Holding Value $0 0 shares
Last Trade
Nov 25, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$243k 3,852 shares
$63.15
$63.14
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $1.49M 59,366 shares
Last Trade
Aug 06, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$143k 5,790 shares
$24.75
$25.10
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $924k 59,366 shares
Last Trade
Aug 06, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$105k 5,790 shares
$18.06
$15.57
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $834k 53,576 shares
Last Trade
Jun 25, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.1k 701 shares
$20.05
$15.57
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $1.34M 53,576 shares
Last Trade
Jun 25, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$17.4k 701 shares
$24.79
$25.10
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $1.33M 52,874 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$75.1k 3,030 shares
$24.79
$25.10
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $823k 52,874 shares
Last Trade
Jun 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60k 3,030 shares
$19.80
$15.57
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $31.3k 26,764 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$350k 26,764 shares
$13.06
$1.17
Envestnet
Envestnet ENV
Director
Holding Value $1.08M 17,075 shares
Last Trade
Feb 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$205k 3,987 shares
$51.53
$63.14
Hercules Capital
Hercules Capital HTGC
Director
Holding Value $743k 47,740 shares
Last Trade
Nov 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.9k 1,200 shares
$15.74
$15.57
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25
Hercules Capital- 6.25% NT REDEEM 30/10/2033 USD 25 HCXY
Director
Holding Value $1.2M 47,740 shares
Last Trade
Nov 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.8k 1,200 shares
$23.99
$25.10

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up